Recovery International Co (TSE:9214) Research & Development: 円0 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:9214 Recovery International Co Ltd TSE:9214
74 GF Score
Price 円1,290.00
GF Value 円3,315.97
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Recovery International Co Research & Development?

Recovery International Co TSE:9214 +0.86% 74 Research & Development is 円0 Mil as of Dec. 2025. GuruFocus rates TSE:9214 with a GF Score™ of 74/100 and a GF Value™ of 円3,315.97 (Significantly Undervalued). The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Recovery International Co's Research & Development for the three months ended in Dec. 2025 was 円0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was 円0 Mil.


Recovery International Co  (TSE:9214) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Recovery International Co Research & Development Related Terms


Recovery International Co Research & Development Historical Data

* Premium members only.

The historical data trend for Recovery International Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Recovery International Co Research & Development Chart

Recovery International Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Recovery International Co Quarterly Data
Dec19 Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:9214
74GF Score
Recovery International Co Ltd TSE:9214
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Recovery International Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of 円0 Mil mean?
Recovery International Co (TSE:9214) has a Research & Development of 円0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Recovery International Co and its competitors.
Is Recovery International Co's Research & Development too high?
Recovery International Co's current Research & Development is 円0 Mil. Overall, Recovery International Co has a GF Score™ of 74/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Recovery International Co's Research & Development compare to HCA and THC?
Recovery International Co's Research & Development of 円0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Recovery International Co and its competitors. Recovery International Co's current Research & Development is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Recovery International Co stock overvalued right now?
Based on GuruFocus' analysis, Recovery International Co (TSE:9214) is currently considered Significantly Undervalued. The stock's GF Value™ is 円3,315.97, compared to a current price of 円1,290.00 — trading 61.1% below its estimated fair value. The current Research & Development is 円0 Mil. Recovery International Co's overall GF Score™ is 74/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Recovery International Co (TSE:9214), the current Research & Development is 円0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Recovery International Co (TSE:9214) Overvalued in 2026?

Based on GuruFocus' analysis, Recovery International Co stock appears to be undervalued. The current stock price of 円1,290.00 is trading 61.1% below its estimated GF Value™ of 円3,315.97. GuruFocus considers Recovery International Co to be Significantly Undervalued.

Key valuation signals for TSE:9214:

  • Research & Development: 円0 Mil
  • GF Value™: 円3,315.97 vs. price of 円1,290.00 (61.1% below fair value)
  • GF Score™: 74/100 with 1 warning sign

No single metric tells the full story. See the TSE:9214 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Recovery International Co Business Description

Address 6-16-12 Nishi-Shinjuku, 6th Floor, Japan Daiichi Maruzen Building, Shinjuku-ku, Tokyo, JPN, 160-0023
Recovery International Co Ltd is engaged in the provision of home-visit nursing services. The company's services include home-visit nursing, rehabilitation, and visit massage.
74GF Score

Get the complete analysis for TSE:9214

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,290.00
Price
円3,315.97
GF Value